Literature DB >> 9205730

Early impairment of foveal magno- and parvocellular pathways in juxta chiasmal tumours.

N J Gutowski1, J R Heron, M O Scase.   

Abstract

Foveal pathway visual function was assessed in 11 patients having tumours extending into the suprasellar region but without evidence of visual impairment as assessed by visual acuity and Bjerrum screen campimetry. Psychophysical and routine visual evoked potential (VEP) measurements were obtained from the eye ipsilateral to the maximal suprasellar extension. The sensitivity of luminance and chromatic pathways was assessed psychophysically by measuring increment thresholds for white and red flashes of light presented on a white adapting field. Temporal sensitivity was assessed psychophysically by measuring threshold modulation sensitivity for sinusoidally modulating stimuli (de Lange attenuation characteristic). The patient group showed approximately equal significant psychophysical losses in chromatic, luminance and temporal sensitivities relative to normal controls. Midline VEP P100 latencies of the patient group did not significantly differ from those of the normal control group. It is concluded that tumours extending into the suprasellar region can cause foveal pathway dysfunction affecting both magno- and parvocellular pathways, even in the presence of normal visual acuity and fields suggesting a more widespread and insidious abnormality of the visual pathways in this condition than previously thought.

Entities:  

Mesh:

Year:  1997        PMID: 9205730     DOI: 10.1016/s0042-6989(96)00306-9

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  7 in total

Review 1.  Neurology of the pituitary gland.

Authors:  J R Anderson; N Antoun; N Burnet; K Chatterjee; O Edwards; J D Pickard; N Sarkies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

2.  Early unilateral macular sensitivity changes in microperimetry in a case of pituitary adenoma.

Authors:  M R Romano; Martina Angi; Vito Romano; Joaquin Marticorena; Ferdinando Romano
Journal:  Int Ophthalmol       Date:  2010-02-23       Impact factor: 2.031

3.  Reversible dysfunction of retinal ganglion cells in non-secreting pituitary tumors.

Authors:  Lori M Ventura; Frank X Venzara; Vittorio Porciatti
Journal:  Doc Ophthalmol       Date:  2008-08-01       Impact factor: 2.379

4.  Functional assessment of magno, parvo and konio-cellular pathways; current state and future clinical applications.

Authors:  Ali Yoonessi; Ahmad Yoonessi
Journal:  J Ophthalmic Vis Res       Date:  2011-04

5.  The clinical value of the multi-channel PVEP and PERG in the diagnosis and management of the patient with pituitary adenoma: a case report.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-07-02       Impact factor: 2.379

Review 6.  The importance of the electrophysiological tests in the early diagnosis of ganglion cells and/or optic nerve dysfunction coexisting with pituitary adenoma: an overview.

Authors:  Ewelina Lachowicz; Wojciech Lubiński
Journal:  Doc Ophthalmol       Date:  2018-10-29       Impact factor: 2.379

7.  The electrophysiological tests in the early detection of the visual pathway dysfunction in patients with microadenoma.

Authors:  Ewelina Lachowicz; Wojciech Lubiński; Wojciech Gosławski; Elżbieta Andrysiak-Mamos; Agnieszka Kaźmierczyk-Puchalska; Anhelli Syrenicz
Journal:  Doc Ophthalmol       Date:  2021-03-20       Impact factor: 2.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.